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Summary: Renal inulin clearance remains the standard by which other methods of measuring glomerular filtration
rate are judged. A fully automated enzymatic assay capable of use with linear configuration inulin was recently
published (Summerfield AL, et al. Clin Chem 1993; 39:2333—7). Sinistrin, a readily soluble preparation of poly-
fructan with side branching, is more suitable for clinical use and far more widely used in Europe. By modifying
the incubation phase of samples with inulinase, incorporating a kinetic modification to the method of fructose
analysis, and increasing the buffer strengths, we report a fully automated system, with minimal sample prehandling
capable of complete sinistrin hydrolysis, and adapted for use on the Cobas Mira.
Introduction
The measurement of inulin clearance as a marker of glo-
merular filtration rate provides the most accurate assess-
ment of renal function. It is subject neither to extra renal
metabolism, nor tubular handling, not bound by plasma
proteins and capable of free passage through the glomer-
ular basement membrane (1).
Its clinical use has been restricted by several difficulties.
Firstly, the insolubility of standard inulin (linear config-
uration (1,2-linked) polyfructan) renders its use for pa-
tient injection difficult. Secondly, the acid hydrolysis of
inulin prior to assaying liberated fructose requires con-
siderable laboratory time, especially when concentrated
and corrosive reagents are used for the additional pur-
pose of deproteination. Finally colorimetric determina-
tion of fructose is not specific (2).
Recent modifications have incorporated the use of an
enzymatic assay for fructose, either to the endpoint of
substrate consumption, (using Bergmeyer's original
combination of hexokinase, glucose-6-phosphate dehy-
drogenase and phosphoglucose isomerase) (3) or similar
combinations (4), or more suitable for automation a ki-
netic assay based on sorbitol dehydrogenase (5)2).
The use of commercially available synergistic combina-
tion of exo- and endo-inulinases2) has enabled a fully
automated enzymatic assay (6). Our own trials of this
method worked well with linear configuration inulin,
once adapted to employ a kinetic assay for fructose. This
adaptation is more suitable to a reaction which results in
a small free energy change, leaving a substantial quan-
tity of substrate in equilibrium with product. This modi-
fication has also recently been reported by the same
group (7).
Sinistrin is a branched polyfructan first reported by
Schmeideberg in 1879 (see fig. 1). Its natural source is
as an energy storage compound in the bulb of the North
') This work was supported by a grant from the St Heller Research
Trust Fund.
2) Enzymes
Novozym 230, a synergistic combination of inulinases:
Exoinulinase:
2,1-ß-jD-Fructan fructanhydrolase EC 3.2.1.7
Endoinulinases:
Fructan-ß-fructosidase EC 3.2.1.80
Indicator reaction catalyzed by:
Sorbitol dehydrogenase EC 1.1.1.14.
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Fig. 1 The structure of sinistrin, consisting of a linear l ,2-linked ß-D-fructose polymer backbone with
t\vo or more 2,6-linked levanbiose side chains.
Inulin
African root vegetable Red Squill, Urginea maritima. Its
greater solubility allows far greater ease of handling and
preparation for injection for clearance studies. Its degree
of polymerisation, consequent relative molecular mass,
and equivalent maximum radius from hydrodynamic
studies (8) indicate a satisfactory permeability through
the glomerular basement membrane, confirmed in sub-
sequent clinical studies (9).
Sinistrin has proved considerably less amendable to en-
zymatic cleavage than linear inulin, we report a fully
automated method capable of complete sinistrin hydrol-
ysis.
for fructan content. Confirmation of steady state is sought by com-
parison of the 110 with 120 min polyfructan concentration.
Reagents
Novozym 2302), a synergistic combination of inulinases (EC
3.2.1.7), with reported activity 1.8 MU/1, was obtained as a liquid
concentrate from Novo Nordisk Enzyme Process Division. Sorbitol
dehydrogenase (EC 1.1.1.14) as lyophilisate, preweighed 2mg
NADH vials, crystalline fructose, and three natural source inulin
preparations (Dahlia Tuber, Dahlia variabilis, Chicory Root,
Cichorium intybus, and Jerusalem Artichoke, Helianthus tubero-
sus) were obtained from Sigma Chemical Co. Ltd. (Poole, Dorset).
Sinistrin (Inutest™) was obtained from Laevosan-Gesellschaft,
(Linz, Austria) in pharmaceutical grade vials for clinical use.
Materials and Methods
Specimens
Plasma samples were taken as part of inulin infusion clearance
examinations from healthy volunteers, its use has already been well
described (10, 11). This method of analysis of inulin clearance is
more suitable in patients with normal or high glomerular filtration
rates such as the diabetic hyperfiltering patients we are studying,
being less prone to errors from delay to steady state inulin concen-
tration, and delayed equilibration with muscle and fascial tissue
compartments. It entails the administration of a bolus dose of sin-
istrin proportionate to volume of distribution, and a continuous in-
fusion at a rate anticipated to bring the serum steady state concen-
tration to a predetermined target, calculated from previous esti-
mates of clearance. Two samples are taken from the contralateral
arm of semirecumbent subjects 2 h after commencement of the in-
fusion. Together with a sample of the infusate these are analysed
Methods
We adapted the previously described method (6) for use on a Cobas
Mira (Roche Diagnostic Systems, Welwyn, UK), incorporating a
1250s predilution phase, a shorter path length for colorimetry,
based on a kinetic analysis of the conversion of fructose to sorbitol,
and two fructose standards for calibration with each run. The Mira
programme is given in table 1.
Serum samples were stored at 4 °C for up to one week, or frozen
and kept at —20 °C for up to 3 months. Urine and infusate samples
were diluted twenty-fold in radioimmunoassay grade bovine serum
albumin, 40 g/1 before the assay.
A 150 aliquot of Novozym 230 was diluted in 5 ml of 500
mmol/l sodium dihydrogen phosphate buffer at pH 4.5 to form the
dilution solution. The final concentration of the inulinases being
40.5 kU/1. The sorbitol dehydrogenase was dissolved in 1 mol/1
hydroxyethyl piperazineethanesulphonic acid (KEPES) buffer, pH
7.7, a°t 4 kU/1. The final reaction concentration being 0.53 units in
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Tab. 1 Cobas Mira Programme (for detailed explanation see the
manufacturer's instructions):
Test INU (Inulinases present) Test INA (Inulinases Absent)
Measurement Mode: Absorb
Reaction Mode: D-R-S
Calibration Mode: Slope Avg
Reagent Blank: Reag/Sol
Cleaner: No
Wavelength: 340 nm
Decimal Posn: 1
Unit: mg/1
Analysis
Dilution Name: INI
Factor: 4.00
Time: 1250 s
Std: Factor
Sample Cycle: 1
Volume: 50.0 μΐ
Dilution Name: H2O
Volume: 15.0 μΐ
Reagent Cycle: 1
Volume: 133 μΐ
Reac. Direction: Decrease
Check: On
Convers. Factor: 1.00000
Offset: 0.00000
Test Range Low: 0.0 mg/1
High: 400.0 mg/1
Number Of Steps: 1
Calc. Step A: Endpoint
Readings First: 4 Last: 19
Calibration Interval: Each Run
Blank Sol-Pos: 7
Standard Pos: l
Std-1; 200 mg/1
Std-2; 200 mg/1
Deviation: 1.5%
Measurement Mode: Absorb
Reaction Mode: D-R-S
Calibration Mode: Slope Avg
Reagent Blank: Reag/Sol
Cleaner: No
Wavelength: 340 nm
Decimal Posn: 1
Unit: mg/1
Analysis
Dilution Name: INO
Factor: 4.00
Time: No
Std: Factor
Sample Cycle: 1
Volume: 50.0 μΐ
Dilution Name: H2O
Volume: 15.0 μΐ
Reagent Cycle: 1
Volume: 133 μΐ
Reac. Direction: Decrease
Check: On
Convers. Factor: 1.00000
Offset: 0.00000
Test Range Low: 0.0 mg/1
High: 100.0 mg/1
Number Of Steps: 1
Calc. Step A: Endpoint
Readings First: 4 Last: 19
Calibration Interval: Each Run
Blank Sol-Pos: 8
Standard Pos: l
Std-1; 200 mg/1
Std-2; 200 mg/1
Deviation: 1.5%
Ratios Racks Reagent 10
TING
Test
A: INU
B:INI*
Decimal Posn: 1
Unit: mg/1
Formula A-B
Factor: 1.0
Rack Posn:
1
2
3
4
INI*
INU
INO**
INA
* INI = Diluent for INU (with inulinases)
** ΓΝΟ = Diluent for INA (no inulinases)
198 μΐ. A sample of 6 ml of this preparation was added to a 2 mg
vial of NADH to form the reagent solution. This ensured blank
absorbance readings of 1.0 to 1.2 at 340 nm. The final reaction
concentration of NADH is 44 μg in 198 μΐ.
The volume of sample taken by the Mira is approximately 80 μΐ
for predilution 1 in 4 with the inulinase solution. Incubation at
37 °C follows for nearly 21 min, 50 cycles on the Mira. From
this a 50 μΐ aliquot was mixed with 133 μΐ of reagent solution.
Colorimetry followed from the 4th to the 19th subsequent cycles.
Eur J Clin Chem Clin Biochem 1995; 33 (No 8)
A separate run was performed on each sample with and without
Novozym in the diluent buffer. This enables a separate determina-
tion of the free fructose content prior to polyfructan hydrolysis.
From the two runs the inulin or sinistrin content may be calculated.
Complete assay time for inulin and free fructose concentration
from 15 samples amounts to 38 min. Two 200 mg/1 fructose stan-
dards in bovine serum albumin were used as calibrators for each
run. Blanks contained 150 μΐ of the respective programme diluent,
and 50 μΐ sodium dihydrogen phosphate buffer.
When stored at 4 °C, sorbitol dehydrogenase retains its activity for
14 days and Novozym 230 was active for over 6 months.
The correlation coefficients were determined by Pearson's method.
The comparison of data on the assay of fructans and fructose were
analysed by linear regression. Both were calculated using a Systat
5.02 statistics programme.
Results
Our initial experiments, based on the use of an endpoint
determination of sorbitol generation, with an increased
path length of 1250 seconds gave poor linearities above
fructose concentrations of 250 mg/1 in prepared stan-
dards, despite substantial increases in sorbitol dehydro-
genase concentration. By shortening the path length con-
siderably and reducing the sorbitol dehydrogenase to ex-
amine a reaction velocity-related absorbance change, af-
ter Dalton & Turner (5), we were able to obtain linear
results up to 400 mg/1 of fructose.
We found it necessary to augment the strength of the
phosphate buffer to 500 mmol/1 in order to reliably bring
the pH of serum samples after dilution to near the opti-
mal range for Novozym's chief components, pH 4.7
(12). As a corollary, HEPES buffer also needed to be
considerably stronger, to subsequently elevate the pH to
optimal for sorbitol dehydrogenase, at 7.4 (13).
Having used linear configuration inulin as a source for
standards we were able to corroborate (6) a full and lin-
ear recovery of fructose from inulin. Allowing for a 6%
impurity by weight of water and non-reducing sugars
(Sigma quote 2—4% water content at time of manufac-
ture), we found r = 0.999, linear regression y = 0.98x
+ 2.35 mg/1, for standards from 0 to 400 mg/1 in bovine
serum albumin. In the presence of 50 mmol glucose in
the samples, this correlation and regression was iden-
tical.
However on changing the source of our polyfructan to
sinistrin, we found a consistent recovery of only 56% of
the equivalent weight of fructose. Prolonging the incu-
bation time to minimum of two hours at room temper-
ature was sufficient to release 107% of the equivalent
weight of crystalline fructose, just short of the 111.1%
appropriate to hexose hydrolysis.
After a variety of experiments with enzyme combina-
tions capable of levanase activity (2,6-polyfructan hy-
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drolysis), we found that only a considerable excess of
Novozym 230, was sufficient to maximally hydrolyse
sinistrin in the desired preincubation time of 1250 s on
the Mira. Comparison of our fructose yields by the assay
with 24 h manual incubations of the same samples in
plasma at 22 °C demonstrated near equivalent hydroly-
sis, y = 0.971x + 2.78 mg/1 (n = 70). This was un-
changed by further increasing the incubation concentra-
tion of Novozym to 67.5 kU/1.
After these modifications, our recovery of fructose from
sinistrin against fructose standards, as analysed by linear
regression was y = 1.067x + 0.05 mg/1, r = 1.000, and
in the presence of 54.3 mmol glucose standards, there
appeared to be a minor effect on the greater concentra-
tions of inulinase, y = 1.053x - 1.13 mg/1, r = 1.000.
Interassay variation for whole clearance determination
on the same set of samples was satisfactory, with CV at
4.4% (number of sample sets = 25, no of runs = 10).
Following our prospectively determined practice of re-
jecting results with a greater than 10 mg/1 variation be-
tween any duplicate samples, the CV for repeated clear-
ance determinations was 2.8% (n = 19). We have deter-
mined a range of infusion clearance values in 16 healthy
volunteers of 112.9 (± standard deviation 16.8) ml/min,
corrected for a surface area of 1.73 m2.
We confirmed that bovine serum albumin has a matrix
effect in augmenting fructose recovery (6). With our as-
say this amounted to an additional 9%. This appears to
be attributable in part to the sorbitol dehydrogenase con-
version of fructose, standards prepared in bovine serum
albumin consistently showed a 6% greater absorbance
change compared to those in deionised water.
Finally we found that exposure of serum samples to
62 °C for 5 min was sufficient to inactivate sorbitol de-
hydrogenase, for sample preparation for patients whose
serum was likely to contain substantial quantities of it,
theoretically capable of altering the kinetics of the reac-
tion. This mainly pertains in hepatocellular disease. This
brief heating did not precipitate plasma proteins or de-
tectably hydrolyse sinistrin.
Discussion
Polyfructans are an abundant energy storage compound
in plants, and the lack of a hydrolytic enzyme system in
mammals render them ideal as inert markers of renal
clearance. The levanbiose (levans being ß-2,6-linked po-
lyfructans) side chains found in sinistrin augment the
compound's solubility, but tender it considerably less
susceptible to exo- and endo-inulinase attack. Novo-
zym's synergistic combination of 3 endoinulinases (EC
3.2.1.7), 5 exoinulinases (EC 3.2.1.80 and EC 3.2.1.26)
with one enzyme of predominant irrtartase activity (also
EC 3.2.1.26) (12, 14), is derived from Aspergillus fi-
cuum. Some purified fungal exoinulinase and endoinuli^
nases from another species of Aspergillus have been in-
effective in cleaving levans (14, 15). Only more profli-
gate varieties of exoinulinase, termed fructan ß-fructosi-
dases (EC 3.2.1.80) have levanase activity (14), and this
seems to be an important discriminant in their classifica-
tion. We found that a concentration 169 times greater
than previously reported was necessary for maximal hy-
drolysis of sinistrin (6), and that description employed
a 100-fold greater concentration than had been found
necessary for the complete liberation of fructose from
linear inulin up to 300 mg/1. Additionally we were
obliged to include a prolonged incubation time, and con-
siderably stronger buffers to ensure optimal pH for hy-
drolytic activity.
These observations underline the importance of ensur-
ing the extent of sinistrin hydrolysis in enzymatic
assays. A decrement in yield from incomplete hydroly-
sis might not be apparent if sinistrin standards were
used as calibrators. Furthermore a differential decre-
ment in fructose yields from plasma as opposed to
urine or infusate samples, arising from a failure to
adequately lower pH in samples with a stronger intrin-
sic buffering system could entail serious miscalcula-
tions of clearance.
Preliminary work suggests a very similar performance
for Novo's currently available inulinase preparation
Fructozyme, derived from A. niger.
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